What is EDURANT® (rilpivirine)?

EDURANT® is a prescription medicine that is used with:

  • other antiretroviral medicines to treat Human Immunodeficiency Virus (HIV-1) in people 12 years of age and older and who weigh at least 77 lbs (35 kg) who:
    • have never taken HIV medicines before, and
    • have an amount of HIV-1 in their blood (this is called ‘viral load’) that is no more than 100,000 copies/mL
  • oral VOCABRIA (cabotegravir) for short term treatment of HIV-1 infection in people 12 years of age or older and who weigh at least 77 lbs (35 kg) when their healthcare professional determines that they meet certain requirements.

HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).

If you take EDURANT® in combination with oral VOCABRIA (cabotegravir), you should also read the Patient Information that comes with oral VOCABRIA (cabotegravir).

It is not known if EDURANT® is safe and effective in children less than 12 years of age or who weigh less than 77 lbs (35 kg).

Once you and your doctor have decided that EDURANT® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. We will give you information on your insurance coverage, potential out-of-pocket costs, and treatment support, and identify options that may help make your treatment more affordable.

Call a Janssen CarePath Care Coordinator today at 1-866-836-0114, Monday-Friday, 8:00 AM to 8:00 PM ET, create a Janssen CarePath Account at MyJanssenCarePath.com or visit JanssenCarePath.com

+